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Summary
Background The Patient-Oriented Eczema Measure (POEM), scored 0–28, is the
core outcome instrument recommended for measuring patient-reported atopic
eczema symptoms in clinical trials. To date, two published studies have broadly
concurred that the minimally important change (MIC) of the POEM is three
points. Further assessment of the MIC of POEM in different populations, and
using a variety of methods, will improve interpretability of the POEM in research
and clinical practice.
Objectives To calculate the smallest detectable change in the POEM and estimate
the MIC of the POEM using a variety of methods in a trial dataset of children
with moderate-to-severe atopic eczema.
Methods This study used distribution-based and anchor-based methods to calculate
the MIC of the POEM in children with moderate-to-severe eczema.
Results Data were collected from 300 children. The smallest detectable change was
213. The MIC estimates were 107 (using 02 SD of baseline POEM scores) and
268 (using 05 SD of baseline POEM scores) based on distribution-based meth-
ods; were 309–613 based on patient-/parent-reported anchor-based methods;
and were 323–538 based on investigator-reported anchor-based methods.
Conclusions We recommend the following thresholds be used to interpret changes
in POEM scores: ≤ 2, unlikely to be a change beyond measurement error; 21–
29, a small change detected that is likely to be beyond measurement error but
may not be clinically important; 3–39, probably a clinically important change;
≥ 4, very likely to be a clinically important change.
What’s already known about this topic?
• The Patient-Oriented Eczema Measure (POEM) is recommended as the core outcome
instrument for measuring patient-reported symptoms in eczema clinical trials.
• Two previous studies have examined the minimally important change (MIC) of the
POEM; one in children with mild eczema and another in adults with very severe
eczema.
• These previous studies both concluded that the MIC in POEM is around three
points.
What does this study add?
• This study explored the impact of different methodologies for calculating the MIC
of the POEM in children with moderate-to-severe eczema.
• A change in POEM of less than two points is likely to be below the smallest detect-
able change (i.e. below measurement error) for the scale.
• The MIC varied considerably depending on the method used, but a change in
POEM score below three points is unlikely to be a clinically important change.
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What are the clinical implications of this work?
• This study aids sample size calculations for clinical trials and helps researchers, clin-
icians and patients to interpret changes in POEM scores in clinical trials and routine
monitoring of eczema in clinical practice.
Minimally important change (MIC) has been defined as ‘the
smallest change in score in the construct to be measured
which patients perceive as important’.1 The Patient-Oriented
Eczema Measure (POEM) measures patient-reported eczema
severity, scored out of 28. Seven questions ask how frequently
a symptom has occurred over the past week on a five-point
scale from ‘no days’ to ‘every day’.2 The Harmonising Out-
come Measures in Eczema (HOME) initiative, which is devel-
oping the core outcome set for atopic eczema clinical trials,
has recommended all clinical trials measure patient-reported
symptoms using the POEM.3 The National Institute for Health
and Care Excellence guidance for clinical practice with chil-
dren under 12 years old recommends use of the POEM.4
Understanding the MIC of the POEM can support sample size
calculations for clinical trials and interpretation of trial
results.5 MIC estimates also allow clinicians to interpret a
patient’s change in the POEM score in the clinical setting and
aid decisions regarding whether a treatment alteration is
required.5
There is a variety of terminology used to explain the con-
cept of MIC, the most common alternatives being the minimal
clinically important difference (MCID) and minimally impor-
tant difference (MID). MIC tends to be used to refer to
longitudinal within-person changes in scores, and MID for
cross-sectional between-person differences.6 For consistency,
we have used MIC throughout this study. There is an ongoing
debate about whether the methods currently used are appro-
priate to estimate the MID.7
One of the major challenges for determining the MIC for a
patient-reported outcome is that an MIC is not a fixed attri-
bute, but is a variable concept that can be influenced by a
number of factors including methods used to calculate it and
baseline disease severity.5,8,9 There are broadly two main
approaches that are used to calculate the MIC: anchor-based
approaches and distribution-based approaches. In anchor-based
approaches, a certain amount of change on an external crite-
rion, which should ideally be a related and well interpretable
outcome measure (the ‘anchor’), is said to correspond to an
MIC on the measuring instrument of interest.9 Distribution-
based approaches are based on the distributional characteristics
of the sample.9
The MIC of the POEM was previously estimated using a
patient-reported anchor for the ‘within-patient’ score change
method as 34 points in a study using datasets from two trials
in adults with severe eczema.10 Subsequently, a study using
data from a trial in children with mild to moderate eczema
aged between 1 month and 5 years from primary care used a
combination of anchor-based and distribution-based methods
to calculate the MIC. Results ranged from 25 to 427, which
led the authors to conclude that the results broadly concurred
with an MIC of three points.11
It has been recommended that researchers use multiple
methods and multiple datasets to triangulate MIC results.12–14
Although a multitude of MIC estimates could detract from the
usefulness of a universal MIC threshold, it is important to
explore how the MIC of the POEM may vary to ensure it is
meaningful in the context used.
One concept that helps interpret change on a patient-
reported outcome measure is the smallest detectable change.
The smallest detectable change is defined as a change beyond
measurement error.9 A change in POEM score that is greater
than the smallest detectable change has 95% chance of being a
true change in score rather than a random variation in the
way people answer the POEM. The MIC of the POEM must be
greater than the smallest detectable change to be useful. To
date, the smallest detectable change of the POEM has not been
assessed.15
Using the dataset from the CLOTHES trial, which was a
6-month randomized controlled trial to assess wearing silk
clothing compared with usual care in children with moder-
ate-to-severe eczema,16 the present study aimed to: (i) calcu-
late the smallest detectable change in the POEM; (ii) estimate
the MIC of the POEM by repeating methods used in previous
studies and using additional methods; and (iii) assess
whether using a patient/parent or investigator static global
assessment as an anchor influences the anchor-based MIC
estimates.
Patients and methods
The study protocol was registered on the Centre of Evidence
Based Dermatology’s Protocol Registration on 5 January 2017
prior to data analysis: http://www.nottingham.ac.uk/research/
groups/cebd/resources/protocol-registration.aspx.
The CLOTHES trial
The CLOTHES trial is a parallel-group, randomized, controlled,
observer-blind trial. Children aged 1–15 years were recruited
from secondary care and the community and allocated to wear
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either silk garments plus standard care or standard care only.
At study entry, one of the eligibility criteria was that partici-
pants had either a moderate (9–11) or severe (12–15) score
on the Nottingham Eczema Severity Score.16,17
Measures
POEM measures patient-reported frequency of itch, sleep,
bleeding, weeping/oozing, cracking, and flaking and dryness/
roughness over the past week.2 Each item is weighted equally
and scored as 0 (no days), 1 (1–2 days), 2 (3–4 days), 3
(5–6 days) or 4 (every day).2 This analysis used POEM scores
at baseline and at 6 months from the CLOTHES dataset. A
Patient’s/Parent’s Global Assessment (P/PGA) and Investiga-
tor’s Global Assessment of Severity (IGA) were also used
(these measures are described in Table 2).
Statistical analysis
The total POEM score was calculated by adding together the
score from each item. If one item was missing the total score
was still calculated, but total score was coded as missing if
more than two items were missing.18 As only 9% of data col-
lected at 6 months was missing, all analyses used complete
case series. POEM scores from patients in both the treatment
and control arm were not treated separately in this study.
Except where stated otherwise, the statistical package Stata 14
was used to run analyses (StataCorp, College Station, TX,
U.S.A.). No formal sample size was conducted, but the num-
ber of patients included in the analysis is likely to be suffi-
cient. It has been recommended that validation studies contain
at least 100 participants.9
Calculating the smallest detectable change
The smallest detectable change was calculated as 196 9 ﬃﬃﬃ2p
9 SEM.9 The standard error of measurement (SEM) was calcu-
lated as SD(pooled) 9
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ICCp .
SDðpooledÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SDðbaselineÞ2 þ SDð6monthsÞ2
q
2
The intraclass correlation coefficient (ICC) for absolute
agreement was derived from the test–retest reliability of the
POEM, which was tested in the development of the POEM.2
This was considered acceptable as there is similar variability in
the CLOTHES data (SD(baseline) = 536) and the dataset used
initially to validate the POEM by Charman et al. (SD(baseline) is
773).2
Calculating the minimally important change (MIC)
Distribution-based methods Two distribution-based methods were
used to estimate the MIC. An effect size is measured by the
difference between the score at baseline and follow-up,
divided by the standard deviation of the baseline score.19 05
multiplied by the standard deviation of POEM scores at base-
line was used as an estimate of the MIC.20 It has been sug-
gested that the MIC should correspond to a smaller effect size,
therefore 02 multiplied by the standard deviation of POEM
scores at baseline was also used.19
Anchor-based methods Four anchor-based methods were used to
estimate the MIC. The IGA and P/PGA scores were trans-
formed into a change score to provide an anchor: score at
time point 1 (baseline) minus score at time point 2
(6 months). This creates change scores on the IGA and P/PGA
that can range from –5 (worsened eczema severity) to 5 (im-
proved eczema severity), that were used as anchors. The MIC
was operationally defined as a positive one-point change on
the P/PGA or the IGA anchor to indicate a minimal important
improvement. This change indicates a change in severity band-
ing on the P/PGA/IGA (e.g. from moderate to mild). This is
also the cut-off used by Schram et al., enabling comparisons
with previous MIC estimates.10
For an anchor to be useful it must at least moderately corre-
late with the POEM change score (r ≥ 03).13 This was
assessed prior to the study with Pearson’s r correlations
between the POEM change scores and (i) the P/PGA change
scores (r = 055) and (ii) the IGA change scores (r = 046),
and both met this minimum criterion. The assumptions of
Pearson’s r correlations were met.
The first two anchor-based methods used mean change to
analyse (i) ‘within-patient’ score change where the MIC is
estimated as the mean change score of the smallest reported
improvement (a positive one-point change in the anchor)
and (ii) ‘between-patient’ score change where the MIC esti-
mate is based on the relative change between the mean
change score of the group with the smallest reported
improvement on the anchor (a positive one-point change)
and the mean change score of the group with no change on
the anchor.
The third anchor-based method used the receiver operating
characteristic (ROC) curve. The area under the curve of the
ROC curve identifies the cut-off point on the POEM change
scores that most optimally distinguishes between the anchor
of IGA or P/PGA change scores ≤ 0 and IGA or P/PGA change
scores ≥ 1.19 The cut-off used to provide an MIC estimate will
maximize the Youden J statistic: sensitivity – (1 – speci-
ficity).19 We used the statistical package R (R Foundation,
Vienna, Austria) to use bootstrapping methods to allow us to
calculate an MIC estimate with 95% confidence intervals
(CIs).21
The fourth anchor-based method used predictive modelling.
This method uses logistic regression to predict whether a
patient belongs to the improved (≥ 1) or not improved group
(≤ 0) on the IGA or P/PGA anchor using the change in POEM
score as the predictor.21 The MIC is estimated using the equa-
tion [ln(pre-odds) – C]/B, where C is the intercept and B is
the regression coefficient for the change in POEM score from
the logistic regression model. The pre-odds is calculated using
the proportion improved based on the anchor divided by 1
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minus the proportion improved based on the anchor.21 The
Microsoft Excel spreadsheet designed to aid confidence interval
calculations of predictive modelling MIC estimates provided in
supplementary materials by Terluin et al. was used.21 It has
been suggested that if the proportion improved on the anchor
does not equal 05, an adjusted MIC may need to be calcu-
lated.22 As the proportion improved on the IGA anchor was
056 and the P/PGA anchor was 053, we have not reported
the adjusted MIC here.
Results
A total of 300 children with atopic eczema were randomized
into the CLOTHES trial and completed the POEM at baseline;
174 (58%) were female and the majority were of white ethnic
origin (n = 237, 79%). At 6 months, 273 participants (91%)
had an assessment visit, therefore 273 patients were included
in the anchor-based MIC methods that required this time
point. Table 1 summarizes the age, disease severity and POEM
scores of the sample. Figure 1 provides the distribution of
POEM scores at baseline.
Smallest detectable change
The smallest detectable change is a change beyond measure-
ment error. The intraclass correlation coefficient was 09847
and the pooled SD was 621, therefore the smallest detectable
change in the CLOTHES dataset was 213 points on POEM.
Minimally important change
The MIC of the POEM was analysed using two distribution-
based methods and four anchor-based methods. Figure 2 sum-
marizes the results of the MIC estimates for each method.
Distribution-based methods
As shown in Table 1, the SD of POEM scores at baseline was
536. Using 05 SD of baseline scores gave an MIC of 268
points (95% CI 25–289) and using 02 SD of baseline scores
gave an MIC of 107 points (95% CI 100–116).
Anchor-based methods
Table 2 shows how the IGA anchor and P/PGA anchor were
created.
Mean change methods – the ‘within-patient’ score change and the ‘between-
patient’ score change As presented in Table 3, when using the IGA
as the anchor, the mean change score of the POEM was 202
for those with a change score of zero (no change on the IGA)
and 525 for those with a score of one (defined as minimal
improvement on the IGA). Therefore, for the ‘within-patient’
score change method the MIC is 525 (95% CI 404–646)
and for the ‘between-patient’ score change method the MIC is
323 (95% CI 151–495).
As presented in Table 3, when using the P/PGA as the
anchor, the mean change score of the POEM was 304 for
those with a change score of zero (no change on the P/PGA)
and 613 for those with a score of one (defined as minimal
improvement on the P/PGA). Therefore, for the ‘within-
patient’ score change method the MIC is 613 (95% CI 482–
744) and for the ‘between-patient’ score change method the
MIC is 309 (95% CI 125–494).
ROC curve method The MIC using the IGA anchor was 538
(95% CI 15–85) and the MIC using the P/PGA anchor was
475 (95% CI 35–65).
Predictive modelling method Table 4 contains the results of the
logistic regression analyses that were used to calculate the MIC
and confidence intervals. Using IGA as the anchor, the MIC
estimate using predictive modelling was 443 (95% CI 221–
674). Using the P/PGA anchor, the MIC estimate was 452
(95% CI 281–629).
Discussion
This study showed the smallest detectable change on the
POEM is 213 points. Therefore, only MIC estimates above
213 can be considered a change beyond measurement error.
Using the CLOTHES trial dataset, the MIC estimates of this
study ranged from 107 (using 02 SD of baseline POEM
scores) to 613 (using an IGA as the anchor for the ‘within-
patient’ score change method). The method used should be
considered when interpreting published MIC values as it has
clearly had an impact on estimates in this study. There is still
debate over which method should be used, hence the pluralis-
tic approach used in this study. There is a trade-off between
convenient, hence widely used, distribution-based approaches
and more theoretically appropriate anchor-based approaches.
Anchor-based approaches, unlike distribution-based
approaches, include an explicit judgement of the importance
of the change.23 Nevertheless, it has been suggested MIC esti-
mates using 05 SD corresponded well with anchor-based
methods.24 Within anchor-based approaches, the methods are
evolving to become increasingly sophisticated, first with the
development of the ROC curve method for use in this scenario
Table 1 Summary of participant demographics and Patient-Oriented
Eczema Measure (POEM) scores
n Mean  SD Minimum Maximum
Age (years) 300 506  363 1 15
Nottingham
Eczema
Severity Score
300 1313  162 9 15
POEM
Baseline 300 1695  536 4 28
6 months 273 1216  695 0 28
Change scores 273 478  714 –21 24
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and more recently the development of the predictive mod-
elling method. The two anchors, the IGA and the P/PGA,
were in agreement for some methods, but not others. For
example, the MIC estimates using the two anchors were very
close for the predictive modelling approach, but not for the
ROC curve methods. We cannot provide firm conclusions as
to why this is the case. It could be because of the ROC curve
method being more sensitive to random sampling variation.21
Fig 1. Distribution of baseline Patient-
Oriented Eczema Measure (POEM) scores.
Fig 2. Summary of minimally important
change (MIC) estimates by method used. IGA,
Investigator’s Global Assessment; P/PPGA,
Patient’s/Parent’s Global Assessment.
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However, it could be because of the genuine differences in
patient and investigator scoring of global severity.
The results of the distribution-based methods suggest that
an effect size of 05 corresponds better to the anchor-based
methods than using an effect size of 02.20,25 As the MIC
result from the 02 SD method was below the smallest detect-
able change we would not recommend this method be used
in the future. However, both distribution-based methods pro-
duced lower MIC estimates than anchor-based methods. Either
distribution-based methods are underestimating the MIC, or it
is quite possible that the anchors used here were too broad to
capture smaller yet important changes.
Gaunt et al. used multiple methods and reported a variation
in the MIC ranging from 25 to 427 points in a sample of
children with milder eczema than the sample in the current
study.11 Schram et al. used an anchor-based method and
reported an MIC of 34 in adults with severe eczema.10 We
have synthesized the findings from these previously published
studies and the current study to provide recommendations of
how to interpret changes on the POEM (Table 5).
There is a balance to be struck when estimating sample
sizes for powering trials.26 Powering to detect a nonclinically
important change is unethical and wasteful, as it will result in
overly large trials. However, an underpowered trial based on
Table 2 Measures used for anchors
Measure name Question
Response options
(tick one box) Completed by:
Times collected to
be used for anchors:
Static Patient’s/Parent’s
Global Assessment
(P/PGA)
How is your/your
child’s eczema today?
Clear
Almost clear
Mild
Moderate
Severe
Very severe
Parent/legal guardian
of child with eczema
or child themselves
if old enough
(individual decision)
Baseline
6 months
Static Investigator’s
Global Assessment
(IGA)
How is the child’s
eczema today?
Clear
Almost clear
Mild
Moderate
Severe
Very severe
Research nurse
(excluded measure
when different nurse
completed at different
time points)
Baseline
6 months
Table 3 Mean Patient-Oriented Eczema Measure (POEM) change scores for participants classified according to change on anchors (n = 273)
Investigator’s Global Assessment (IGA) Patient’s/Parent’s Global Assessment (P/PGA)
Change in score on IGA n (%)
Mean POEM change
score  SD Change in score on P/PGA n (%)
Mean POEM change
score  SD
5 0 (0) n/a 5 0 (0) n/a
4 0 (0) n/a 4 0 (0) n/a
3 0 (0) n/a 3 0 (0) n/a
2 1 (04) 1 (n/a) 2 9 (33) 3  964
1 24 (88) 154  677 1 38 (139) 079  482
0 95 (348) 202  601 0 81 (297) 304  588
1 111 (407) 525  643 1 92 (337) 613  633
2 33 (121) 1067  601 2 38 (139) 905  592
3 9 (33) 1589  717 3 10 (37) 118  457
0 (0) n/a 4 5 (18) 182  563
5 0 (0) n/a 5 0 (0) n/a
n/a, not applicable.
Table 4 Logistic regression results used for predictive modelling
minimally important change estimates
Investigator’s
Global Assessment
(IGA)
Patient’s/Parent’s
Global Assessment
(P/PGA)
Pre-oddsa 1257 1133
C  standard error 0293  0159 0598  0171
B  standard error 0121  0022 0160  0025
Correlation of C and Bb 0570 0615
aOdds of improvement based on anchor only; bthis was calcu-
lated using IBM SPSS Statistics 22 (IBM, Armonk, NY, U.S.A.)
and was required as part of the calculation of 95% confidence
intervals.
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detecting a large change in the POEM that provides inconclu-
sive results and wide confidence intervals is also unacceptable.
The recommendations provided in this article should remain
as guidelines. Rather than relying on fixed values to interpret
the importance of a change on the POEM, researchers and clin-
icians should consider the context within which they are using
the POEM. A small improvement in many individuals could
result in a large reduction in burden at a societal level.
This study has some strengths and limitations. It estimated
the MIC of the POEM using a broad array of methods but only
in one dataset, which may limit the generalizability of the
results beyond children in the U.K. with moderate-to-severe
eczema. However, Gaunt et al. and Schram et al. used similar
methods to calculate the MIC, which has allowed us to com-
pare the results across these different populations.10,11 This
study also included methods that have not previously been
used to determine the MIC of the POEM.
The anchors used were determined by what was available
in the CLOTHES dataset, which may not best conceptualize an
MIC. The anchor did not ask about the importance of the
change to the patients/parents or the investigator, which has
been a criticism of anchors generally used to calculate MIC
estimates.8 Furthermore, there is concern that the anchor-
response categories may be too broad to capture the smallest
amount of change that is important to patients, as MIC is
equated to a change on severity banding in a global assess-
ment, and it could be argued that smaller changes are clini-
cally meaningful. The anchors were also static (asked about
today), whereas POEM asks about the last week.
The ICC of the POEM has only been calculated in one
study, and this was used to assess the smallest detectable
change.2 The sample age from the original study completing
the test–retest reliability ranged from 12 months to 62 years,
compared with the CLOTHES trial age range of 1–15 years.
Further investigation of the test–retest agreement would be
useful to increase the reliability of the ICC estimate.
This study should improve the interpretability of change
scores for users of the POEM, be this for clinical trial sample
size calculations and interpretation of findings or for use in
clinical practice. However, there are still areas where under-
standing of the MIC could be further developed. If the ICC of
the POEM used here is found to be inaccurate in subsequent
studies, the smallest detectable change of the POEM should be
replicated. In the meantime, users of the POEM should be cau-
tious in claiming any clinical importance of a change in POEM
scores of two points or less. This study used one trial dataset
of patients with eczema to look at the MIC of the POEM. Fur-
ther work should assess how patient characteristics such as
eczema severity, age, sex and ethnicity influence the MIC.
In conclusion, given the wide spread of MIC estimates gen-
erated using a variety of methods, the method used to calcu-
late the MIC should be given careful consideration. Based on
the evidence available for interpreting change in the POEM,
we suggest that no change in score that is two points or under
should be considered beyond measurement error and that
changes in scores should usually be three points or above
before the change is deemed to be clinically important.
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